Imugene off to strong start to 2023 with JP Morgan Healthcare Conference
News release
by
Imugene Ltd
Melbourne, Victoria
|
January 23, 2023 11:45 AM Eastern Standard Time
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive it has been a busy and productive start to the new year with a number of presentations including at the JP Morgan Healthcare Conference. The company also presented an oral abstract and several poster sessions on its HER-Vaxx and CF33 technologies at the ASCO Gastrointestinal Cancers Symposium in the US.
Contact Details
Proactive Investors
Jonathan Jackson
+61 413 713 744
